C6 and urinary bladder cancer: Validation for complement C6 expression in an independent cohort (Fig. 3C) demonstrated significant reduction in C6 protein levels in low grade bladder cancer patients when compared to healthy controls (p = 0.046) which is consistent with the 2D-DIGE protein expression data.